Japanese hemophilia patients monitored on alhemo in real-world safety study
NCT ID NCT06285071
First seen Jun 15, 2026 · Last updated Jun 15, 2026
Summary
This study looks at how well the drug Alhemo works and how safe it is for people with hemophilia A or B when used in normal medical care in Japan. About 23 participants will take Alhemo as their doctor prescribes and be followed for 2 years. The main goal is to count any side effects, including serious ones or allergic reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital of the University of Occupational And Environmental Health Japan_Pediatrics
Kitakyusyu-shi, Fukuoka, 807 8555, Japan
-
Kagoshima City Hospital_Pediatrics
Kagoshima, 890-8760, Japan
-
Kyushu university hospital_Pediatrics
Fukuoka, 812-8582, Japan
-
Mutsu general hospital_Pediatrics
Aomori, 035-8601, Japan
-
Nanbu Medical Center & Children's Medical Center_Hematology and Oncology
Okinawa, 901-1193, Japan
-
Novo Nordisk Investigational Site
Toshima City, Tokyo, Japan
-
Ogikubo Hospital_Blood Coagulation
Tokyo, 167-0035, Japan
-
Sapporo Tokushukai Hospital_Pediatrics
Hokkaido, 004-0041, Japan
-
St. Marianna University School of Medicine Hospital_Pediatrics
Kanagawa, 216-8511, Japan
-
Tokyo Medical University Hospital
Tokyo, 160-0023, Japan
-
University of the Ryukyus Hospital_Endocrinology and Metabolism, Hematology and Rheumatology
Okinawa, 901-2725, Japan
Conditions
Explore the condition pages connected to this study.